EWTX stock

Edgewise Therapeutics Inc (EWTX) financials · $3.75B cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Edgewise Therapeutics Inc (EWTX) $3.75B cap.

Cached annual income statement
LineFY2025FY2024
Operating Income-$191.4M-$158.8M
Net Income-$167.8M-$133.8M
EPS (Diluted)-$1.63-$1.45
Cached annual balance sheet
LineFY2025FY2024
Total Assets$552.6M$486.8M
Current Assets$543.4M$475.5M
Cash & Equivalents$61.1M$41.7M
PP&E$7.83M$9.50M
Total Liabilities$30.3M$27.6M
Current Liabilities$27.4M$23.9M
Shareholders' Equity$522.3M$459.2M
Retained Earnings-$546.4M-$378.6M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$143.8M-$109.0M
CapEx$256.0K$1.31M
Investing Cash Flow-$32.8M-$184.7M
Financing Cash Flow$196.1M$249.3M
Net Change in Cash$19.5M-$44.4M
Free Cash Flow-$144.1M-$110.3M
These statements as JSON? API free 100/day

FAQ

What is EWTX P/E and revenue?

Edgewise Therapeutics Inc (EWTX) $3.75B cap.

What is EWTX revenue?

EWTX income-statement cache has no revenue figure yet.

Is EWTX profitable?

Edgewise Therapeutics Inc last cached net income is -$167.8M (FY2025).

What are EWTX total assets?

Edgewise Therapeutics Inc last cached total assets are $552.6M (FY2025).

What is EWTX free cash flow?

Edgewise Therapeutics Inc last cached free cash flow is -$144.1M (FY2025).

Not investment advice. Cached statements, not a live tape.